Clinical Trial Update: A Study of ZT002 Injection in Adult Chinese Subjects With Type 2 Diabetes Mellitus (T2DM) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study of ZT002 Injection in adults with Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• ZT002 Injection

Snippet

Sponsor: Beijing QL Biopharmaceutical Co.,Ltd | Conditions: Type 2 Diabetes | Phase 1, Phase 2 | Status: COMPLETED